We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Avacta Life Sciences Takes on the $55BN Antibody Market with Launch of Affimers

News   Sep 30, 2014

 
Avacta Life Sciences Takes on the $55BN Antibody Market with Launch of Affimers
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Retina Restoration Could Return Vision to Our Canine Friends

News

A stem cell-based approach is being developed to treat blindness in dogs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE